Collaborations & Alliances
Related Searches:
Filter by:
796 - 810 of 1091 results
September 10, 2008
Cellzome, Inc. and GlaxoSmithKline entered a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases. The alliance gives GSK access to Cellzome's expertise in identifying and deve…
Read More »
September 4, 2008
Merck Serono has entered into an agreement with Ablynx to discover and develop Nanobodies against two targets in oncology and immunology. The agreement includes an upfront cash payment to Ablynx of $14.5 million.
Nanobodie…
Read More »
September 3, 2008
Pfizer and Medivation, Inc. have entered into an agreement to develop and commercialize Dimebon, Medivation’s investigational drug for treatment of Alzheimer’s disease and Huntington’s disease. Dimebon currently is being studied in…
Read More »
September 3, 2008
Millipore Corp. and Agilent Technologies have formed a collaboration to develop ChIP (chromatin immunoprecipitation) kits for the epigenetics research market. The kits will be designed to improve productivity for protein research and simplify the way…
Read More »
September 2, 2008
InterMune, Inc. earned a $15 million development milestone under its collaboration with Roche for the hepatitis C virus (HCV) NS3 protease inhibitor compound ITMN-191 (R7227), currently in a Phase Ib combination trial with Pegasys (peginterferon alfa…
Read More »
August 28, 2008
Valeant Pharmaceuticals and GlaxoSmithKline have entered into an exclusive worldwide collaboration for the investigational drug retigabine, a neuronal potassium channel opener for treatment of adult epilepsy patients with refractory partial onset sei…
Read More »
August 21, 2008
Boehringer Ingelheim has extended research funding for another year in its Alzheimer's disease collaboration with Ablynx. In January 2007 the companies entered into a $265 million worldwide research and licensing agreement to discover and develop new…
Read More »
August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.
Elotuzumab o…
Read More »
August 19, 2008
Cellumen, Inc., a discovery toxicology company, entered an agreement with Mitsubishi Tanabe Pharma Corp. (MTPC), to develop panels of biomarkers that identify toxicity early in the drug development process.
“We’re pl…
Read More »
August 14, 2008
Tekmira Pharmaceuticals Corp. has entered into a research collaboration with Bristol-Myers Squibb using Tekmira's SNALP technology to deliver small interfering RNAs (siRNAs) to specific organs and tissues outside of the liver.
T…
Read More »
August 11, 2008
Alnylam Pharmaceuticals has formed an exclusive research agreement with the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, to investigate the molecular mechanisms of small interfering RNA (siRNA), the molecules that…
Read More »
August 6, 2008
Covance has signed a definitive agreement with Lilly to help transform Lilly’s R&D model. Under the agreement, Covance will acquire Lilly’s 450-acre early drug development campus in Greenfield, IN for $50 million and will offer employ…
Read More »
August 5, 2008
Tolerx reached a clinical milestone in its collaboration with Genentech, as that company recently moved a modified version of TRX1, MTRX1011A, an anti-CD4 monoclonal antibody, into a Phase I clinical trial. The trial is evaluating the safety and tole…
Read More »
August 5, 2008
Abingdon Life Sciences has entered into an agreement with Stason Pharmaceuticals to provide clinical and regulatory support for Stason’s drug development programs. As part of the agreement, Abingdon will provide clinical and regulatory services…
Read More »
August 1, 2008
Amgen has licensed a clinical stage molecule for the treatment of chronic and neuropathic pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company. The terms of the agreement include a $50 million upfront payment, $…
Read More »
796 - 810 of 1091 results
